These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24334751)

  • 41. Toxicity testing in the 21st century: bringing the vision to life.
    Andersen ME; Krewski D
    Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH).
    Kamath GH; Rao KS
    Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From alternative methods to a new toxicology.
    Hartung T
    Eur J Pharm Biopharm; 2011 Apr; 77(3):338-49. PubMed ID: 21195172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotoxicity testing: moving beyond qualitative "screen and bin" approach towards characterization of dose-response and thresholds.
    Pottenger LH; Gollapudi BB
    Environ Mol Mutagen; 2010; 51(8-9):792-9. PubMed ID: 20806283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic toxicology.
    Kramer PJ
    J Pharm Pharmacol; 1998 Apr; 50(4):395-405. PubMed ID: 9625484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic toxicology. Principles and methods. Preface II.
    Methods Mol Biol; 2012; 817():vii-xi. PubMed ID: 22250336
    [No Abstract]   [Full Text] [Related]  

  • 50. In silico approaches to genetic toxicology: progress and future.
    Benigni R
    Mutagenesis; 2019 Mar; 34(1):1-2. PubMed ID: 30059987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Industrial Genotoxicology Group: novel in vivo genotoxicity assays, Royal Society of Medicine, London, UK, December 1992.
    Jones E
    Mutagenesis; 1994 Jan; 9(1):79-80. PubMed ID: 8208135
    [No Abstract]   [Full Text] [Related]  

  • 52. Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies.
    Donaldson K; Poland CA; Schins RP
    Nanotoxicology; 2010 Dec; 4():414-20. PubMed ID: 20925449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational toxicology--a state of the science mini review.
    Kavlock RJ; Ankley G; Blancato J; Breen M; Conolly R; Dix D; Houck K; Hubal E; Judson R; Rabinowitz J; Richard A; Setzer RW; Shah I; Villeneuve D; Weber E
    Toxicol Sci; 2008 May; 103(1):14-27. PubMed ID: 18065772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. History of the American College of Toxicology (ACT).
    Christian MS
    Int J Toxicol; 2004; 23(5):285-99. PubMed ID: 15513830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
    Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
    Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The future of toxicity testing.
    Andersen ME; Al-Zoughool M; Croteau M; Westphal M; Krewski D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):163-96. PubMed ID: 20574896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of high-content screening applications in toxicology.
    Li S; Xia M
    Arch Toxicol; 2019 Dec; 93(12):3387-3396. PubMed ID: 31664499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
    Doktorova TY; Pauwels M; Vinken M; Vanhaecke T; Rogiers V
    Crit Rev Toxicol; 2012 Feb; 42(2):91-106. PubMed ID: 22141324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consensus recommendations to promote and advance predictive systems toxicology and toxicogenomics.
    Waters M; Yauk C
    Environ Mol Mutagen; 2007 Jun; 48(5):400-3. PubMed ID: 17567851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.